Exhibit 107
Calculation of Filing Fee Tables
S-8
(Form Type)
Acer Therapeutics Inc.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered Securities
Security Type | Security Class Title | Fee Calculation Rule | Amount (1) | Proposed Price Per Unit (2) | Maximum Price | Fee Rate | Amount of Fee | |||||||||
Fees to be Paid | Equity | Common Stock, $0.0001 par value per share | 457(c), 457(h) | 772,410 (3) | $2.55 | $1,969,644.89 | $0.0000927 | $182.59 | ||||||||
Total Offering Amounts | $1,969,644.89 | |||||||||||||||
Total Fee Offsets | ||||||||||||||||
Net Fee Due | $182.59 |
(1) | Pursuant to Rule 416(a) under the Securities Act of 1933 (the “Securities Act”), this Registration Statement also covers an indeterminate number of additional shares of common stock to be offered or sold pursuant to the above-named plan that may be issued as a result of the anti-dilution and other adjustment provisions therein by reason of certain corporate transactions or events, including any stock dividend, stock split, recapitalization or other similar transaction effected without the receipt of consideration which results in an increase in the number of the registrant’s outstanding shares of common stock. |
(2) | Computed in accordance with Rules 457(c) and (h) under the Securities Act, solely for the purpose of calculating the registration fee, based on the average of the high and low prices of the common stock as reported on the Nasdaq Capital Market on February 25, 2022. |
(3) | Includes 200,000 shares of common stock reserved for issuance exclusively for the grant of inducement awards to eligible recipients granted pursuant to the 2018 Stock Incentive Plan in compliance with Nasdaq Marketplace Rule 5635(c)(4). |